Sionna Therapeutics (NASDAQ:SION) Shares Up 5.6% - Here's Why

Sionna Therapeutics, Inc. (NASDAQ:SION - Get Free Report) shot up 5.6% during trading on Monday . The stock traded as high as $16.12 and last traded at $14.54. 39,502 shares traded hands during mid-day trading, a decline of 81% from the average session volume of 204,829 shares. The stock had previously closed at $13.77.

Analyst Ratings Changes

SION has been the topic of several analyst reports. Guggenheim started coverage on Sionna Therapeutics in a research report on Tuesday. They set a "buy" rating and a $45.00 price target on the stock. Stifel Nicolaus began coverage on shares of Sionna Therapeutics in a research note on Tuesday. They issued a "buy" rating and a $32.00 target price on the stock. Finally, TD Cowen initiated coverage on shares of Sionna Therapeutics in a research report on Tuesday. They set a "buy" rating for the company.

Sionna Therapeutics Stock Performance

Sionna Therapeutics Company Profile

We are a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (“CF”) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (“CFTR”) protein to deliver clinically meaningful benefit to CF patients.